To date, more than 90 fusion partners have been reported, of which three major partner genes are responsible for nearly 90% of KMT2A-r infant ALL: AFF1 (49%), MLLT1 (22%) or MLLT3 (16%)37. Here, AFF1 is linked to acute lymphoblastic leukemia.